Fat-Stem is the first company in Europe to use adipose-derived mesenchymal stem cells for therapeutic use in animals. We spoke with Guy Wouters, founder and CEO of Fat-Stem, about how it all started, how the company grew and how the company operates today. He gives us insight into the regulatory framework for cell therapies in veterinary medicine and how it differs from human medicine. In addition, he shares some examples of animals that have been successfully treated with cell therapies, developed by Fat-Stem. Become a member of the at.las network and watch the whole interview on the at.las academy.